BACH1 and acute myeloid leukemia: The results showed that the protein expression of FBXO22 was negatively correlated with BACH1 protein level in primary AML patients, and patients with higher FBXO22 protein expression had lower BACH1 protein expression and vice versa (Fig. 5J, K).